Opticyte announced today that its Cell O2 patient monitor received breakthrough device designation from the FDA. Seattle-based Opticyte designed Cell O2 to use noninvasive optical spectroscopy technology. It measures and detects systemic low oxygen levels inside cells. This provides continuous monitoring of cellular oxygen levels during hospitalization. The startup said in a news release it […]